Request for Covid-19 Impact Assessment of this Report
The United States Metoclopramide market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Metoclopramide market, reaching US$ million by the year 2028. As for the Europe Metoclopramide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Metoclopramide players cover Teva, Sanofi, Astellas, and Adwya, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Metoclopramide market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Oral
Injection
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Nausea
Migraine
Gastroparesis
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Teva
Sanofi
Astellas
Adwya
Biofarma
Apotex
Novartis
ASKA Seiyaku Asuka
Yang Sheng
Meda Pharma
Johnson and Johnson
GSK
Alkaloid Pharmaceuticals
Teuto Brasileiro
Mylan
EU-Pharma
Le Vet
Omega Laboratories
Orion Pharma
Pfizer
Wockhardt
Amneal Pharmaceuticals
Nidda
Ceva Sante Animale
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Metoclopramide Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Metoclopramide by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Metoclopramide by Country/Region, 2017, 2022 & 2028
2.2 Metoclopramide Segment by Type
2.2.1 Oral
2.2.2 Injection
2.3 Metoclopramide Sales by Type
2.3.1 Global Metoclopramide Sales Market Share by Type (2017-2022)
2.3.2 Global Metoclopramide Revenue and Market Share by Type (2017-2022)
2.3.3 Global Metoclopramide Sale Price by Type (2017-2022)
2.4 Metoclopramide Segment by Application
2.4.1 Nausea
2.4.2 Migraine
2.4.3 Gastroparesis
2.5 Metoclopramide Sales by Application
2.5.1 Global Metoclopramide Sale Market Share by Application (2017-2022)
2.5.2 Global Metoclopramide Revenue and Market Share by Application (2017-2022)
2.5.3 Global Metoclopramide Sale Price by Application (2017-2022)
3 Global Metoclopramide by Company
3.1 Global Metoclopramide Breakdown Data by Company
3.1.1 Global Metoclopramide Annual Sales by Company (2020-2022)
3.1.2 Global Metoclopramide Sales Market Share by Company (2020-2022)
3.2 Global Metoclopramide Annual Revenue by Company (2020-2022)
3.2.1 Global Metoclopramide Revenue by Company (2020-2022)
3.2.2 Global Metoclopramide Revenue Market Share by Company (2020-2022)
3.3 Global Metoclopramide Sale Price by Company
3.4 Key Manufacturers Metoclopramide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Metoclopramide Product Location Distribution
3.4.2 Players Metoclopramide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Metoclopramide by Geographic Region
4.1 World Historic Metoclopramide Market Size by Geographic Region (2017-2022)
4.1.1 Global Metoclopramide Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Metoclopramide Annual Revenue by Geographic Region
4.2 World Historic Metoclopramide Market Size by Country/Region (2017-2022)
4.2.1 Global Metoclopramide Annual Sales by Country/Region (2017-2022)
4.2.2 Global Metoclopramide Annual Revenue by Country/Region
4.3 Americas Metoclopramide Sales Growth
4.4 APAC Metoclopramide Sales Growth
4.5 Europe Metoclopramide Sales Growth
4.6 Middle East & Africa Metoclopramide Sales Growth
5 Americas
5.1 Americas Metoclopramide Sales by Country
5.1.1 Americas Metoclopramide Sales by Country (2017-2022)
5.1.2 Americas Metoclopramide Revenue by Country (2017-2022)
5.2 Americas Metoclopramide Sales by Type
5.3 Americas Metoclopramide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metoclopramide Sales by Region
6.1.1 APAC Metoclopramide Sales by Region (2017-2022)
6.1.2 APAC Metoclopramide Revenue by Region (2017-2022)
6.2 APAC Metoclopramide Sales by Type
6.3 APAC Metoclopramide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Metoclopramide by Country
7.1.1 Europe Metoclopramide Sales by Country (2017-2022)
7.1.2 Europe Metoclopramide Revenue by Country (2017-2022)
7.2 Europe Metoclopramide Sales by Type
7.3 Europe Metoclopramide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Metoclopramide by Country
8.1.1 Middle East & Africa Metoclopramide Sales by Country (2017-2022)
8.1.2 Middle East & Africa Metoclopramide Revenue by Country (2017-2022)
8.2 Middle East & Africa Metoclopramide Sales by Type
8.3 Middle East & Africa Metoclopramide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metoclopramide
10.3 Manufacturing Process Analysis of Metoclopramide
10.4 Industry Chain Structure of Metoclopramide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Metoclopramide Distributors
11.3 Metoclopramide Customer
12 World Forecast Review for Metoclopramide by Geographic Region
12.1 Global Metoclopramide Market Size Forecast by Region
12.1.1 Global Metoclopramide Forecast by Region (2023-2028)
12.1.2 Global Metoclopramide Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Metoclopramide Forecast by Type
12.7 Global Metoclopramide Forecast by Application
13 Key Players Analysis
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Metoclopramide Product Offered
13.1.3 Teva Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Metoclopramide Product Offered
13.2.3 Sanofi Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Astellas
13.3.1 Astellas Company Information
13.3.2 Astellas Metoclopramide Product Offered
13.3.3 Astellas Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Astellas Main Business Overview
13.3.5 Astellas Latest Developments
13.4 Adwya
13.4.1 Adwya Company Information
13.4.2 Adwya Metoclopramide Product Offered
13.4.3 Adwya Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Adwya Main Business Overview
13.4.5 Adwya Latest Developments
13.5 Biofarma
13.5.1 Biofarma Company Information
13.5.2 Biofarma Metoclopramide Product Offered
13.5.3 Biofarma Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Biofarma Main Business Overview
13.5.5 Biofarma Latest Developments
13.6 Apotex
13.6.1 Apotex Company Information
13.6.2 Apotex Metoclopramide Product Offered
13.6.3 Apotex Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Apotex Main Business Overview
13.6.5 Apotex Latest Developments
13.7 Novartis
13.7.1 Novartis Company Information
13.7.2 Novartis Metoclopramide Product Offered
13.7.3 Novartis Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Novartis Main Business Overview
13.7.5 Novartis Latest Developments
13.8 ASKA Seiyaku Asuka
13.8.1 ASKA Seiyaku Asuka Company Information
13.8.2 ASKA Seiyaku Asuka Metoclopramide Product Offered
13.8.3 ASKA Seiyaku Asuka Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 ASKA Seiyaku Asuka Main Business Overview
13.8.5 ASKA Seiyaku Asuka Latest Developments
13.9 Yang Sheng
13.9.1 Yang Sheng Company Information
13.9.2 Yang Sheng Metoclopramide Product Offered
13.9.3 Yang Sheng Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Yang Sheng Main Business Overview
13.9.5 Yang Sheng Latest Developments
13.10 Meda Pharma
13.10.1 Meda Pharma Company Information
13.10.2 Meda Pharma Metoclopramide Product Offered
13.10.3 Meda Pharma Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Meda Pharma Main Business Overview
13.10.5 Meda Pharma Latest Developments
13.11 Johnson and Johnson
13.11.1 Johnson and Johnson Company Information
13.11.2 Johnson and Johnson Metoclopramide Product Offered
13.11.3 Johnson and Johnson Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Johnson and Johnson Main Business Overview
13.11.5 Johnson and Johnson Latest Developments
13.12 GSK
13.12.1 GSK Company Information
13.12.2 GSK Metoclopramide Product Offered
13.12.3 GSK Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 GSK Main Business Overview
13.12.5 GSK Latest Developments
13.13 Alkaloid Pharmaceuticals
13.13.1 Alkaloid Pharmaceuticals Company Information
13.13.2 Alkaloid Pharmaceuticals Metoclopramide Product Offered
13.13.3 Alkaloid Pharmaceuticals Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Alkaloid Pharmaceuticals Main Business Overview
13.13.5 Alkaloid Pharmaceuticals Latest Developments
13.14 Teuto Brasileiro
13.14.1 Teuto Brasileiro Company Information
13.14.2 Teuto Brasileiro Metoclopramide Product Offered
13.14.3 Teuto Brasileiro Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Teuto Brasileiro Main Business Overview
13.14.5 Teuto Brasileiro Latest Developments
13.15 Mylan
13.15.1 Mylan Company Information
13.15.2 Mylan Metoclopramide Product Offered
13.15.3 Mylan Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Mylan Main Business Overview
13.15.5 Mylan Latest Developments
13.16 EU-Pharma
13.16.1 EU-Pharma Company Information
13.16.2 EU-Pharma Metoclopramide Product Offered
13.16.3 EU-Pharma Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 EU-Pharma Main Business Overview
13.16.5 EU-Pharma Latest Developments
13.17 Le Vet
13.17.1 Le Vet Company Information
13.17.2 Le Vet Metoclopramide Product Offered
13.17.3 Le Vet Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Le Vet Main Business Overview
13.17.5 Le Vet Latest Developments
13.18 Omega Laboratories
13.18.1 Omega Laboratories Company Information
13.18.2 Omega Laboratories Metoclopramide Product Offered
13.18.3 Omega Laboratories Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Omega Laboratories Main Business Overview
13.18.5 Omega Laboratories Latest Developments
13.19 Orion Pharma
13.19.1 Orion Pharma Company Information
13.19.2 Orion Pharma Metoclopramide Product Offered
13.19.3 Orion Pharma Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Orion Pharma Main Business Overview
13.19.5 Orion Pharma Latest Developments
13.20 Pfizer
13.20.1 Pfizer Company Information
13.20.2 Pfizer Metoclopramide Product Offered
13.20.3 Pfizer Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Pfizer Main Business Overview
13.20.5 Pfizer Latest Developments
13.21 Wockhardt
13.21.1 Wockhardt Company Information
13.21.2 Wockhardt Metoclopramide Product Offered
13.21.3 Wockhardt Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Wockhardt Main Business Overview
13.21.5 Wockhardt Latest Developments
13.22 Amneal Pharmaceuticals
13.22.1 Amneal Pharmaceuticals Company Information
13.22.2 Amneal Pharmaceuticals Metoclopramide Product Offered
13.22.3 Amneal Pharmaceuticals Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Amneal Pharmaceuticals Main Business Overview
13.22.5 Amneal Pharmaceuticals Latest Developments
13.23 Nidda
13.23.1 Nidda Company Information
13.23.2 Nidda Metoclopramide Product Offered
13.23.3 Nidda Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Nidda Main Business Overview
13.23.5 Nidda Latest Developments
13.24 Ceva Sante Animale
13.24.1 Ceva Sante Animale Company Information
13.24.2 Ceva Sante Animale Metoclopramide Product Offered
13.24.3 Ceva Sante Animale Metoclopramide Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Ceva Sante Animale Main Business Overview
13.24.5 Ceva Sante Animale Latest Developments
14 Research Findings and Conclusion
Table 1. Metoclopramide Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Metoclopramide Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Injection
Table 5. Global Metoclopramide Sales by Type (2017-2022) & (K Units)
Table 6. Global Metoclopramide Sales Market Share by Type (2017-2022)
Table 7. Global Metoclopramide Revenue by Type (2017-2022) & ($ million)
Table 8. Global Metoclopramide Revenue Market Share by Type (2017-2022)
Table 9. Global Metoclopramide Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Metoclopramide Sales by Application (2017-2022) & (K Units)
Table 11. Global Metoclopramide Sales Market Share by Application (2017-2022)
Table 12. Global Metoclopramide Revenue by Application (2017-2022)
Table 13. Global Metoclopramide Revenue Market Share by Application (2017-2022)
Table 14. Global Metoclopramide Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Metoclopramide Sales by Company (2020-2022) & (K Units)
Table 16. Global Metoclopramide Sales Market Share by Company (2020-2022)
Table 17. Global Metoclopramide Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Metoclopramide Revenue Market Share by Company (2020-2022)
Table 19. Global Metoclopramide Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Metoclopramide Producing Area Distribution and Sales Area
Table 21. Players Metoclopramide Products Offered
Table 22. Metoclopramide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Metoclopramide Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Metoclopramide Sales Market Share Geographic Region (2017-2022)
Table 27. Global Metoclopramide Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Metoclopramide Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Metoclopramide Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Metoclopramide Sales Market Share by Country/Region (2017-2022)
Table 31. Global Metoclopramide Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Metoclopramide Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Metoclopramide Sales by Country (2017-2022) & (K Units)
Table 34. Americas Metoclopramide Sales Market Share by Country (2017-2022)
Table 35. Americas Metoclopramide Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Metoclopramide Revenue Market Share by Country (2017-2022)
Table 37. Americas Metoclopramide Sales by Type (2017-2022) & (K Units)
Table 38. Americas Metoclopramide Sales Market Share by Type (2017-2022)
Table 39. Americas Metoclopramide Sales by Application (2017-2022) & (K Units)
Table 40. Americas Metoclopramide Sales Market Share by Application (2017-2022)
Table 41. APAC Metoclopramide Sales by Region (2017-2022) & (K Units)
Table 42. APAC Metoclopramide Sales Market Share by Region (2017-2022)
Table 43. APAC Metoclopramide Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Metoclopramide Revenue Market Share by Region (2017-2022)
Table 45. APAC Metoclopramide Sales by Type (2017-2022) & (K Units)
Table 46. APAC Metoclopramide Sales Market Share by Type (2017-2022)
Table 47. APAC Metoclopramide Sales by Application (2017-2022) & (K Units)
Table 48. APAC Metoclopramide Sales Market Share by Application (2017-2022)
Table 49. Europe Metoclopramide Sales by Country (2017-2022) & (K Units)
Table 50. Europe Metoclopramide Sales Market Share by Country (2017-2022)
Table 51. Europe Metoclopramide Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Metoclopramide Revenue Market Share by Country (2017-2022)
Table 53. Europe Metoclopramide Sales by Type (2017-2022) & (K Units)
Table 54. Europe Metoclopramide Sales Market Share by Type (2017-2022)
Table 55. Europe Metoclopramide Sales by Application (2017-2022) & (K Units)
Table 56. Europe Metoclopramide Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Metoclopramide Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Metoclopramide Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Metoclopramide Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Metoclopramide Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Metoclopramide Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Metoclopramide Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Metoclopramide Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Metoclopramide Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Metoclopramide
Table 66. Key Market Challenges & Risks of Metoclopramide
Table 67. Key Industry Trends of Metoclopramide
Table 68. Metoclopramide Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Metoclopramide Distributors List
Table 71. Metoclopramide Customer List
Table 72. Global Metoclopramide Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Metoclopramide Sales Market Forecast by Region
Table 74. Global Metoclopramide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Metoclopramide Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Metoclopramide Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Metoclopramide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Metoclopramide Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Metoclopramide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Metoclopramide Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Metoclopramide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Metoclopramide Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Metoclopramide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Metoclopramide Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Metoclopramide Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Metoclopramide Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Metoclopramide Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Metoclopramide Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Metoclopramide Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Metoclopramide Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Metoclopramide Revenue Market Share Forecast by Application (2023-2028)
Table 92. Teva Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 93. Teva Metoclopramide Product Offered
Table 94. Teva Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Teva Main Business
Table 96. Teva Latest Developments
Table 97. Sanofi Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 98. Sanofi Metoclopramide Product Offered
Table 99. Sanofi Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Sanofi Main Business
Table 101. Sanofi Latest Developments
Table 102. Astellas Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 103. Astellas Metoclopramide Product Offered
Table 104. Astellas Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Astellas Main Business
Table 106. Astellas Latest Developments
Table 107. Adwya Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 108. Adwya Metoclopramide Product Offered
Table 109. Adwya Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Adwya Main Business
Table 111. Adwya Latest Developments
Table 112. Biofarma Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 113. Biofarma Metoclopramide Product Offered
Table 114. Biofarma Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Biofarma Main Business
Table 116. Biofarma Latest Developments
Table 117. Apotex Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 118. Apotex Metoclopramide Product Offered
Table 119. Apotex Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Apotex Main Business
Table 121. Apotex Latest Developments
Table 122. Novartis Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 123. Novartis Metoclopramide Product Offered
Table 124. Novartis Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Novartis Main Business
Table 126. Novartis Latest Developments
Table 127. ASKA Seiyaku Asuka Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 128. ASKA Seiyaku Asuka Metoclopramide Product Offered
Table 129. ASKA Seiyaku Asuka Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. ASKA Seiyaku Asuka Main Business
Table 131. ASKA Seiyaku Asuka Latest Developments
Table 132. Yang Sheng Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 133. Yang Sheng Metoclopramide Product Offered
Table 134. Yang Sheng Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Yang Sheng Main Business
Table 136. Yang Sheng Latest Developments
Table 137. Meda Pharma Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 138. Meda Pharma Metoclopramide Product Offered
Table 139. Meda Pharma Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Meda Pharma Main Business
Table 141. Meda Pharma Latest Developments
Table 142. Johnson and Johnson Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 143. Johnson and Johnson Metoclopramide Product Offered
Table 144. Johnson and Johnson Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Johnson and Johnson Main Business
Table 146. Johnson and Johnson Latest Developments
Table 147. GSK Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 148. GSK Metoclopramide Product Offered
Table 149. GSK Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. GSK Main Business
Table 151. GSK Latest Developments
Table 152. Alkaloid Pharmaceuticals Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 153. Alkaloid Pharmaceuticals Metoclopramide Product Offered
Table 154. Alkaloid Pharmaceuticals Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Alkaloid Pharmaceuticals Main Business
Table 156. Alkaloid Pharmaceuticals Latest Developments
Table 157. Teuto Brasileiro Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 158. Teuto Brasileiro Metoclopramide Product Offered
Table 159. Teuto Brasileiro Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Teuto Brasileiro Main Business
Table 161. Teuto Brasileiro Latest Developments
Table 162. Mylan Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 163. Mylan Metoclopramide Product Offered
Table 164. Mylan Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Mylan Main Business
Table 166. Mylan Latest Developments
Table 167. EU-Pharma Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 168. EU-Pharma Metoclopramide Product Offered
Table 169. EU-Pharma Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. EU-Pharma Main Business
Table 171. EU-Pharma Latest Developments
Table 172. Le Vet Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 173. Le Vet Metoclopramide Product Offered
Table 174. Le Vet Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Le Vet Main Business
Table 176. Le Vet Latest Developments
Table 177. Omega Laboratories Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 178. Omega Laboratories Metoclopramide Product Offered
Table 179. Omega Laboratories Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. Omega Laboratories Main Business
Table 181. Omega Laboratories Latest Developments
Table 182. Orion Pharma Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 183. Orion Pharma Metoclopramide Product Offered
Table 184. Orion Pharma Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 185. Orion Pharma Main Business
Table 186. Orion Pharma Latest Developments
Table 187. Pfizer Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 188. Pfizer Metoclopramide Product Offered
Table 189. Pfizer Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 190. Pfizer Main Business
Table 191. Pfizer Latest Developments
Table 192. Wockhardt Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 193. Wockhardt Metoclopramide Product Offered
Table 194. Wockhardt Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 195. Wockhardt Main Business
Table 196. Wockhardt Latest Developments
Table 197. Amneal Pharmaceuticals Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 198. Amneal Pharmaceuticals Metoclopramide Product Offered
Table 199. Amneal Pharmaceuticals Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 200. Amneal Pharmaceuticals Main Business
Table 201. Amneal Pharmaceuticals Latest Developments
Table 202. Nidda Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 203. Nidda Metoclopramide Product Offered
Table 204. Nidda Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 205. Nidda Main Business
Table 206. Nidda Latest Developments
Table 207. Ceva Sante Animale Basic Information, Metoclopramide Manufacturing Base, Sales Area and Its Competitors
Table 208. Ceva Sante Animale Metoclopramide Product Offered
Table 209. Ceva Sante Animale Metoclopramide Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 210. Ceva Sante Animale Main Business
Table 211. Ceva Sante Animale Latest Developments
List of Figures
Figure 1. Picture of Metoclopramide
Figure 2. Metoclopramide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Metoclopramide Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Metoclopramide Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Metoclopramide Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Injection
Figure 11. Global Metoclopramide Sales Market Share by Type in 2021
Figure 12. Global Metoclopramide Revenue Market Share by Type (2017-2022)
Figure 13. Metoclopramide Consumed in Nausea
Figure 14. Global Metoclopramide Market: Nausea (2017-2022) & (K Units)
Figure 15. Metoclopramide Consumed in Migraine
Figure 16. Global Metoclopramide Market: Migraine (2017-2022) & (K Units)
Figure 17. Metoclopramide Consumed in Gastroparesis
Figure 18. Global Metoclopramide Market: Gastroparesis (2017-2022) & (K Units)
Figure 19. Global Metoclopramide Sales Market Share by Application (2017-2022)
Figure 20. Global Metoclopramide Revenue Market Share by Application in 2021
Figure 21. Metoclopramide Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Metoclopramide Revenue Market Share by Company in 2021
Figure 23. Global Metoclopramide Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Metoclopramide Revenue Market Share by Geographic Region in 2021
Figure 25. Global Metoclopramide Sales Market Share by Region (2017-2022)
Figure 26. Global Metoclopramide Revenue Market Share by Country/Region in 2021
Figure 27. Americas Metoclopramide Sales 2017-2022 (K Units)
Figure 28. Americas Metoclopramide Revenue 2017-2022 ($ Millions)
Figure 29. APAC Metoclopramide Sales 2017-2022 (K Units)
Figure 30. APAC Metoclopramide Revenue 2017-2022 ($ Millions)
Figure 31. Europe Metoclopramide Sales 2017-2022 (K Units)
Figure 32. Europe Metoclopramide Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Metoclopramide Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Metoclopramide Revenue 2017-2022 ($ Millions)
Figure 35. Americas Metoclopramide Sales Market Share by Country in 2021
Figure 36. Americas Metoclopramide Revenue Market Share by Country in 2021
Figure 37. United States Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Metoclopramide Sales Market Share by Region in 2021
Figure 42. APAC Metoclopramide Revenue Market Share by Regions in 2021
Figure 43. China Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Metoclopramide Sales Market Share by Country in 2021
Figure 50. Europe Metoclopramide Revenue Market Share by Country in 2021
Figure 51. Germany Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Metoclopramide Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Metoclopramide Revenue Market Share by Country in 2021
Figure 58. Egypt Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Metoclopramide Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Metoclopramide in 2021
Figure 64. Manufacturing Process Analysis of Metoclopramide
Figure 65. Industry Chain Structure of Metoclopramide
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...